Acute iron poisoning and chronic iron overload consequences in significant morbidity and
mortality worldwide. Treatment of acute iron poisoning and chronic iron overload can be …

As an iron chelation therapy, deferasirox (DEF) is commonly used as the primary treatment
drug to prevent intracellular iron overload in patients with thalassemia who require long-term …

The sensitivity and selectivity of potentiometric sensors towards their targets in various
matrices have been challenging for analysts since their development. Modifications of the …

Deferasirox is an oral iron chelator that has been on the market since 2005 and has been a
suitable replacement for injectable chelators. It is important to check the amount of this drug …

January 1, 2009 and December 31, 2010. It is directed exclusively toward the analysis of
compounds in either their bulk or formulated forms and focuses on analytical procedures for …

As an orally active iron chelator, deferasirox forms its ion complexes in the prepared plasma
samples and LC–MS mobile phase where ferric ion exists, and then comparing with the …

The reverse phase high performance liquid chromatographic (RP-HPLC) method has been
developed for simultaneous estimation of starting material, impurities and final product in …

An unknown impurity was detected in deferasirox drug substance by a newly developed
high performance liquid chromatography (HPLC) method. The unknown impurity was …

To determine deferasirox in human breast milk a novel, sensitive high-performance liquid
chromatographic method with fluorescence detection has been developed. Precolumn …

In an effort to discover new molecules with good insecticidal activities, a series of 3, 5‐bis (2‐
hydroxyphenyl)‐1H‐1, 2, 4‐triazole derivatives were synthesized. The X–ray …